STEVENSVILLE, Md., Nov. 7 /PRNewswire-USNewswire/ -� Vapotherm, the
leading developer and manufacturer of High Flow Oxygen Therapy products,
has earned an Export Achievement Certificate from the U.S. Department of
Vapotherm was one of three Maryland companies to receive this
designation at a recent ceremony in Wye Mills, Maryland. The Export
Achievement Certificate was created by the U.S. Department of Commerce to
recognize small and medium-sized enterprises that have successfully entered
the international marketplace for the first time or that have successfully
entered a new market.
"Vapotherm has been on a progressive international expansion course and
we are now distributed in over 20 countries outside the U.S. and our
success abroad has not only provided an important new technology for the
global respiratory community, but it has also helped to strengthen our
domestic base," said Kevin Thibodeau, Vice President of Sales and Marketing
for Vapotherm. The US Department of Commerce Export Assistance and the
State of Maryland Export Assistance has been a valuable resource for use as
we expand globally.
"We are excited about Vapotherm's rapid growth in international
markets. Vapotherm is a great example of a small company that is able to
succeed internationally due to its advanced technology, corporate
leadership and commitment to developing markets overseas. With ninety five
percent of the world's market outside of the United States, Vapotherm is
well positioned in these markets for future growth," said Bill Burwell,
Director of the U.S. Commercial Service in Baltimore.
Vapotherm, Inc. is a privately held manufacturer of respiratory care
devices for hospitals and home care use based in Stevensville, Maryland.
The Company is dedicated to the development of innovative, noninvasive
technologies for respiratory therapy, especially for the treatment of
chronic lung and acute breathing disorders. For more information, visit
SOURCE Vapotherm, Inc.